Previous Article | Next Article 
Molecular and Cellular Biology, March 2001, p. 1573-1580, Vol. 21, No. 5
0270-7306/01/$04.00+0 DOI: 10.1128/MCB.21.5.1573-1580.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
VAMP3 Null Mice Display Normal Constitutive,
Insulin- and Exercise-Regulated Vesicle Trafficking
Chunmei
Yang,1
Silvia
Mora,1
Jeffrey W.
Ryder,1
Kenneth J.
Coker,1,
Polly
Hansen,2
Lee-Ann
Allen,3 and
Jeffrey E.
Pessin1,*
Department of Physiology and
Biophysics1 and Department of Internal
Medicine,3 The University of Iowa, Iowa
City, Iowa 52242, and Department of Cell Biology, Pfizer
Global Research and Development, Ann Arbor, Michigan
481052
Received 19 September 2000/Returned for modification 28 September
2000/Accepted 27 November 2000
 |
ABSTRACT |
To investigate the physiological function of the VAMP3 vesicle
SNARE (v-SNARE) isoform in the regulation of GLUT4 vesicle trafficking,
we generated homozygotic VAMP3 null mice by targeted gene disruption.
The VAMP3 null mice had typical growth rate and weight gain, with
normal maintenance of fasting serum glucose and insulin levels.
Analysis of glucose disposal and insulin sensitivity demonstrated
normal insulin and glucose tolerance, with no evidence for insulin
resistance. Insulin stimulation of glucose uptake in isolated primary
adipocytes was essentially the same for the wild-type and VAMP3 null
mice. Similarly, insulin-, hypoxia-, and exercise-stimulated glucose
uptake in isolated skeletal muscle did not differ significantly. In
addition, other general membrane trafficking events including
phagocytosis, pinocytosis, and transferrin receptor recycling were also
found to be unaffected in the VAMP3 null mice. Taken together, these
data demonstrate that VAMP3 function is not necessary for either
regulated GLUT4 translocation or general constitutive membrane recycling.
 |
INTRODUCTION |
Insulin increases glucose uptake in
adipose and striated muscle tissues primarily by recruiting the GLUT4
glucose transporter protein to the cell surface (37). In
the basal non-insulin-stimulated state, the majority of GLUT4 resides
in one or more intracellular compartments (44, 45). Upon
addition of insulin, the signaling cascade triggered by the insulin
receptor leads to rapid translocation of the GLUT4 transporter to the
plasma membrane, thereby increasing the number of transporters at the
cell surface and the rate of glucose uptake (12, 27, 38,
41).
The process of GLUT4 translocation shares important features with the
exocytosis of synaptic vesicles during neurotransmitter release. For
example, the plasma membrane docking and fusion of GLUT4 vesicles
appears to require the t-SNARE protein isoforms syntaxin 4 and SNAP23
(9, 37, 48). GLUT4 vesicles contain the
v-SNARE-interacting partners VAMP2 and VAMP3, both of which translocate
to the plasma membrane in parallel with GLUT4 (33, 47).
Recent studies using various toxins and endosomal ablation techniques
have indicated that VAMP2 is the predominant v-SNARE responsible for
insulin-stimulated GLUT4 translocation in cultured 3T3-L1
adipocytes and in the L6 muscle cell line (9, 32, 33, 40).
In contrast, guanosine-5'-O-(3-thiotriphosphate) (GTP
S)-stimulated GLUT4 translocation was found to be dependent on
VAMP3, thereby suggesting the presence of two independently regulated
pools of GLUT4 storage compartments (35). In this regard,
skeletal muscle has also been shown to contain two pools of GLUT4
vesicles, one that responds to insulin and another that is
responsive to exercise and contraction (1, 11, 39). In
addition, the skeletal muscle exercise-contraction subpopulation utilizes a signaling pathway independent of the phosphatidylinositol (PI) 3-kinase (30, 31, 50). Similarly, GTP
S stimulation in adipocytes is also independent of the PI 3-kinase, suggesting that
the GTP
S and exercise-contraction pathways may utilize the same populations of intracellular GLUT4 vesicles (18).
In addition to the potential role in GLUT4 translocation, VAMP3 has
also been suggested to play an important functional role in
phagocytosis and general receptor membrane trafficking events (5,
14, 22, 34). Thus, to address the relative contributions of
VAMP3 in insulin- and exercise-contraction-stimulated GLUT4 translocation, glucose uptake, and general membrane trafficking processes, we have generated mice with a homozygotic disruption of the
VAMP3 gene. In this report, we characterize these mice and demonstrate
that they are phenotypically normal in terms of glucose homeostasis,
tissue glucose transport, pinocytosis, and general membrane receptor recycling.
 |
MATERIALS AND METHODS |
Isolation of murine VAMP3 genomic clones.
The full-length
0.4-kb murine VAMP3 cDNA containing the 312-bp open reading frame
(kindly provided by Amira Klip, The Hospital for Sick Children,
Toronto, Ontario, Canada) was sequenced to confirm the identity of the
clone. A panel of PCR oligonucleotide primers encompassing the entire
VAMP3 cDNA (designated A to J) was designed. All 10 possible primer
combinations were tested by PCR amplification of the murine cDNA clone
and yielded products of the expected sizes. Subsequent PCR
amplification of mouse liver DNA using the VAMP3 pair H
(5'-TGAAACAAGTGCTGCCAAGT)-J
(5'-CGATGATGATGATGACAATG) primer pair yielded a product of
965 bp, much larger than the 104-bp H-J product from the cDNA,
indicating the presence of intronic sequences. The genomic H-J product
was subcloned and sequenced, and its identity as part of the mouse
VAMP3 gene was confirmed by BLAST analysis. The H and J primers were
then sent to Genome Systems (St. Louis, Mo.), where a PCR-based screen
of a murine 129/Sv/J library yielded a ~120-kb bacterial artificial
chromosome clone containing the VAMP3 gene. Based on Southern blot
analysis of this clone, 15 kb of the genomic sequence was subcloned and extensively analyzed. This 15-kb fragment contains the entire VAMP3
gene, which has five exons and spans approximately 10 kb of genomic
sequence (accession numbers AF308433 and AF308434).
Generation of the VAMP3 targeting vector.
The VAMP3
targeting vector was constructed by using a positive-negative selection
vector, pOSDUPDEL (obtained from the Gene Targeting Laboratory, The
University of Iowa, Iowa City). The 5' homologous region in the
targeting vector was a 2.3-kb SpeI-BglII fragment
containing intron 1, exon 1 (which ends with AT of the start codon
ATG), and upstream sequences of the VAMP3 gene. This fragment was
inserted into the pOSDUPDEL vector in the
XbaI-BamHI cloning site downstream of the
neomycin phosphotransferase gene (neo) cassette. Orientation
of this fragment was confirmed by restriction enzyme digestion and
sequencing. To generate the 3' homologous region, the 3.3-kb
BglII-BglII fragment containing a portion of
intron 3, exon 4 and 5, 3' untranslated region, and downstream
sequences was isolated and inserted into the vector in the
BclI cloning site upstream of the neo cassette.
Orientation of this fragment was also confirmed by restriction enzyme
digestion and sequencing. The vector contained a thymidine kinase
cassette distal to the 5' homologous region. The mutant gene therefore lacked a 7.8-kb region which included 636 bp of intron 1, exon 2 (containing guanosine of the start codon ATG), intron 2, exon 3 (encoding the entire coiled-coil domain of VAMP3), and 442 bp of intron 3.
Generation of VAMP3 null mice.
The targeting construct was
linearized with PmeI and introduced into 2 × 107 pluripotent embryonic stem (ES) cells (R1 clone) by
electroporation (Gene Pulser; Bio-Rad, Hercules, Calif.). ES clones
that were G418 and ganciclovir resistant were isolated, amplified, and
screened for targeting fidelity by Southern blot analysis (see Fig.
1B). Seventeen targeted clones were obtained from 95 analyzed. Six of
these clones were subsequently reconfirmed by Southern blot analysis,
and the single targeting event was also confirmed by hybridizing the
XbaI-digested ES DNA with a neo probe. Cells from two targeted clones (AA30 and AA60) were microinjected into donor C57BL/6J blastocysts and implanted into pseudopregnant ICR females. Chimeric animals resulting from the microinjections were bred to
C57BL/6J mice, and agouti pups were screened for germ line transmission
of the mutant allele. The genotypes from these matings and all
subsequent matings were determined by PCR on DNA from tail biopsy
specimens. All experimental analyses were performed on matched
littermates from hybrid C57BL/6-129/Sv/J backgrounds. All mice were
housed in the animal care unit of the University of Iowa College of
Medicine according to animal care guidelines.
Western blot analysis.
Tissue extracts were prepared by
dissection and homogenization in lysis buffer (25 mM HEPES [pH 7.4],
1% NP-40, 137 mM NaCl, 1 mM phenylmethylsulfonyl fluoride, 10 µg of
aprotinin/ml, 1 µg of pepstatin/ml, 5 µg of leupeptin/ml, 5 mM
benzamidine) in a Polytron PT-10 homogenizer. The samples were then
centrifuged at 2,000 × g for 5 min, and the
supernatant was recentrifuged at 14,000 × g for 20 min
at 4°C. Total fat membranes were prepared by homogenizing white fat
tissue in HES buffer (255 mM sucrose, 20 mM HEPES [pH 7.4], 1 mM
EDTA), centrifugation at 800 × g for 4 min, and
recentrifugation of the supernatant at 180,000 × g for
70 min at 4°C. Proteins were resolved by sodium dodecyl
sulfate-polyacrylamide gel electrophoresis on 3 to 15% linear gradient
gels and subjected to immunoblotting. The sources of antibodies against
proteins indicated in Fig. 2 were described previously (28,
46).
Metabolic measurements.
Fed and fasted (12 h) blood glucose
measurements were determined with a glucometer (De Centech, St. Paul,
Minn.). Serum insulin was determined by enzyme-linked immunosorbent
assay, using mouse insulin as a standard (ALPCO, Windham, N.H.). Serum
triglyceride, nonesterified free fatty acid, and cholesterol
concentrations were determined by colorimetric assay (WAKO Chemicals,
Richmond, Va.).
GTT and ITT.
Glucose tolerance tests (GTTs) were performed
on mice fasted for 12 h. D-Glucose (20% solution, 2 g/kg of body weight) was injected intraperitoneally into the animals,
and blood glucose values were measured at 0, 30, 60, 90, and 120 min
postinjection. Insulin tolerance tests (ITTs) were performed on mice
fasted for 6 h. Animals were injected intraperitoneally with
Humulin R (0.75 U/kg of body weight; Eli Lilly Corp., Indianapolis,
Ind.), and blood glucose values were determined immediately before and
at 15, 30, and 60 min after injection.
Glucose uptake in primary adipocytes.
The transport of
glucose was determined using 2-deoxyglucose as previously described
(19). Briefly, adipocytes were isolated from epididymal
fat pads by collagenase (2 mg/ml) digestion at 37°C with constant
agitation in Krebs-Ringer buffer containing 15 mM sodium bicarbonate,
10 mM HEPES, 2 mM sodium pyruvate, 200 nM adenosine, and bovine serum
albumin (BSA; 2.5%, wt/vol). The cells were then incubated with or
without 100 nM insulin for 30 min, and
2-deoxy-D-[3H]glucose (final concentration,
0.1 mM; ICN, Costa Mesa, Calif.) was then added for 10 min. The
reaction was terminated by a 30-s spin over dinonylphthalate oil, and
the incorporated radioactivity in the cells was counted. Nonspecific
uptake and trapping in the extracellular space was determined by
measuring uptake in the presence of cytochalasin B.
Insulin-stimulated glucose transport in isolated skeletal
muscle.
Soleus muscles were isolated for incubation in vitro, and
the transport assay was performed as described previously
(23). Unless stated otherwise, all incubation media were
prepared from a pregassed (95% O2-5% CO2)
stock of Krebs-Henseleit bicarbonate buffer (KHB) supplemented with 5 mM HEPES and 0.1% BSA (radioimmunoassay grade). The muscles were
incubated in a shaking water bath (30°C) for 30 min in 1 ml of KHB
supplemented with 5 mM glucose and 15 mM mannitol in the absence or
presence of 120 nM insulin. The muscles were then incubated for 10 min
in glucose-free medium. Thereafter, muscles were transferred to vials
containing 1 mM [3H]2-deoxyglucose (2.5 µCi/ml) and 19 mM [14C]mannitol (0.7 µCi/ml) and incubated for 20 min.
The muscles were dissolved with 0.5 M NaOH, and 2-deoxyglucose uptake
was assessed as described by Hansen et al. (23).
Hypoxia-stimulated glucose transport.
Soleus muscles were
removed for incubation under normoxia or hypoxia, without or with the
addition of insulin. Hypoxic medium was pregassed with 95%
N2-5% CO2. Muscles were preincubated under either normoxic (95% O2-5% CO2) or hypoxic
(95% N2-5% CO2) conditions for 45 min
(30°C) in KHB supplemented with 5 mM D-glucose and 15 mM
mannitol. The specific gas mixture was maintained throughout the
preexposure period. Following preincubation, muscles were transferred
to oxygenated KHB containing 2 mM pyruvic acid and 18 mM mannitol.
Muscles were incubated for 15 min at 30°C under a gas phase of
95%O2-5%CO2 and 2-deoxyglucose uptake was
measured as described above.
Exercise-induced glucose transport.
Mice were exercised by
swimming as described by Ryder et al. (43). Briefly, the
mice were randomly assigned to a sedentary or exercised group and
placed in plastic barrels measuring 45 cm in diameter and filled to a
depth of ~40 cm. Water temperature was maintained at 34 to 35°C.
Mice swam for six 30-min intervals separated by 5-min rest periods.
After the last swim interval, mice were anesthetized, and extensor
digitorum longus (EDL) muscles were removed immediately and incubated
for 15 min in 1 ml of KHB supplemented with 20 mM mannitol.
2-Deoxyglucose uptake was determined as described above.
Macrophage and bacterial cultures.
Bone marrow-derived
macrophages (BMMs) were differentiated from marrow extracted from the
femora of male and female wild-type or VAMP3 null mice in medium
containing HEPES-RPMI 1640, 15% heat-inactivated fetal bovine serum
(FBS), 1% L-glutamine, 100 U of penicillin G/ml, 100 µg
of streptomycin/ml, and 20% L-cell conditioned medium (a source of
colony-stimulating factor 1 [CSF-1]). Mature BMMs were used after a
total of 7 to 19 days in culture. For each experiment, BMMs were
scraped off petri dishes and replated on coverslips or in tissue
culture dishes as indicated. Twelve to 24 h after plating, BMM
were switched to minimal essential medium alpha containing 10%
heat-inactivated FBS and 1% L-glutamine (without
antibiotics or CSF-1) and incubated overnight at 37°C prior to use.
Helicobacter pylori strain 11637 was cultured on Trypticase
soy agar plates containing 5% sheep blood under microaerophilic
conditions as previously described (3).
Phagocytosis assays.
Macrophages were plated on acid-washed
round glass coverslips (12-mm diameter; Fisher, Pittsburgh, Pa.) in
complete medium and then starved of CSF-1 and antibiotics as indicated
above. Unopsonized zymosan particles and zymosan particles opsonized with complement were prepared as described elsewhere (2);
immunoglobulin G (IgG)-opsonized zymosan particles were prepared using
Molecular Probes opsonizing reagent according to the manufacturer's
specifications. One-micrometer-diameter latex beads were the generous
gift of Larry Schlesinger, Department of Medicine, University of Iowa. Washed H. pylori and other particles were dispersed in
tissue culture medium to achieve a ratio of 3 zymosan particles, 10 latex beads, or 25 bacteria per macrophage. For all experiments,
phagocytosis was synchronized by centrifugation as previously described
(2, 3). Intracellular and extracellular cell-associated
bacteria were determined as previously described by immunofluorescence labeling with H. pylori polyclonal antibodies
(24). For all particles, BMMs that had ingested zymosan,
opsonized zymosan, or latex beads for 30 min at 37°C were fixed in
10% buffered formalin and permeabilized in
20°C acetone
(4). Fixed cells were blocked overnight at 4°C in
Dulbecco's phosphate-buffered saline containing 0.5 mg of
NaN3/ml, 5 mg of BSA/ml, and 10% horse serum (blocking buffer). Cell-associated zymosan, opsonized zymosan, and latex beads
were detected by phase-contrast optics. Internalized particles were
identified by staining fixed and permeabilized cells with monoclonal
antibodies to lamp-1 (Developmental Studies Hybridoma Bank, University
of Iowa) and secondary antibodies conjugated to fluorescein
isothiocyanate (goat anti-rat IgG; Jackson ImmunoResearch Laboratories,
West Grove, Pa.) Washed coverslips were mounted on glass slides in
Mowiol, and fluorescence was visualized using a Zeiss Axioplan2
microscope (Carl Zeiss, Inc., Thornwood, N.Y.). For each experiment, at
least 100 infected macrophages were counted on triplicate coverslips.
Transferrin receptor recycling.
Primary mouse embryonic
fibroblasts were isolated from wild-type or VAMP3-deficient mice
following standard procedures (25). Cells were maintain in
Dulbecco modified Eagle medium containing 15% FBS. The transferrin
recycling assay was performed as previously described by Ceresa et al.
(8). Briefly, 35-mm-diameter dishes of cells were depleted
of bovine transferrin and then incubated with
[125I]transferrin (3 nM; 1 µCi/µg) at 4°C for
2.5 h. Unbound ligand was removed by washing the cells with
serum-free medium at 4°C, and internalization was initiated by
warming the cells to 37°C. At various times, endocytosis was blocked
by washing the cells with ice-cold phosphate-buffered saline. The
amount of ligand cell surface bound (acid dissociable), in the medium
(recycled), and internalized (cell-associated acid resistant) was
measured by counting on a Packard Autogamma 5000 counter.
Pinocytosis.
The fluid-phase uptake of horseradish
peroxidase (HRP) was assayed as described by Daro et al.
(13). Briefly, primary mouse embryonic fibroblasts from
wild-type or VAMP3-deficient mice were labeled with 2.5 mg of HRP/ml
Dulbecco modified Eagle medium in DMEM supplemented with 2 mg of BSA/ml
for various times. Cells were then washed extensively, lysed in 1%
Triton X-100, assayed for HRP activity, and normalized to total cell protein.
 |
RESULTS |
Generation of VAMP3-deficient mice.
We initially constructed a
targeting vector in which 7.8 kb of VAMP3 genomic sequence,
including exon 2, which contains the guanosine of the start codon ATG,
and exon 3, which encodes the entire coiled-coil domain of VAMP3, was
replaced with a neo cassette oriented in the opposite
direction as the endogenous VAMP3 gene (Fig.
1A). Of 95 neomycin-resistant ES clones
analyzed, 17 demonstrated the desired mutation, as confirmed by
Southern blot analysis (shown for one clone in Fig. 1B). Two of these
clones were used to generate chimeric founder mice. Heterozygotic mice
from the F1 generation were identified by PCR analysis
(data not shown) and were crossed to obtain VAMP3-deficient mice.
VAMP3-deficient mice were born from heterozygous matings in a predicted
Mendelian inheritance frequency. Figure 1C shows an example of a
Southern blot analysis of the VAMP3 locus of wild-type, heterozygous,
and homozygous mutant mice.

View larger version (29K):
[in this window]
[in a new window]
|
FIG. 1.
Generation of VAMP3-deficient mice by homologous
recombination in ES cells. (A) Schematic representation of the
wild-type murine VAMP3 locus, the targeting construct, and
the targeted locus. A 7.8-kb region including exon 2 (E2) and exon 3 (E3) (black boxes) was replaced by a neo cassette inserted
in the reverse orientation. The 5' and 3' homologous regions of the
targeting construct were 2.3 and 3.3 kb, respectively. TK, thymidine
kinase. Southern blots show genomic DNA extracted from ES cells (B)
and mouse tail (C), using a diagnostic probe (as indicated in panel A).
The wild-type locus generates a 3.5-kb XbaI fragment,
whereas the targeted allele produces a 7-kb XbaI fragment.
|
|
To confirm that VAMP3 protein was not present in the VAMP3-deficient
mice, we performed Western blot analysis of several tissues
from
wild-type, heterozygous, and VAMP3-deficient animals (Fig.
2). The VAMP3 protein is ubiquitously
expressed and found in all
tissues examined. However, expression was
consistently 50% less
in all tissues of the heterozygous knockout mice
and was eliminated
in the VAMP3-deficient mice. Furthermore, the loss
of VAMP3 protein
expression was not compensated for by changes in
several other
SNARE proteins, proteins localized to GLUT4 vesicles, and
other
general endosome trafficking proteins. These data demonstrate
that this conventional genomic replacement results in the
complete
ablation of VAMP3 protein expression without any specific
compensatory
changes in protein expression.

View larger version (46K):
[in this window]
[in a new window]
|
FIG. 2.
VAMP3-deficient mice do not express VAMP3 but maintain
normal expression levels of GLUT4 and other related proteins. Tissue
extracts from heart (Hrt), skeletal muscle (Skm), white adipose tissue
(Wat), brain (Br), liver (Liv), testis (Tes), kidney (Kid), and lung
(Lu) were separated by sodium dodecyl sulfate-polyacrylamide gel
electrophoresis and immunoblotted for VAMP3, GLUT4, insulin-responsive
aminopeptidase (IRAP), transferrin receptor (TfR), syntaxin 4 (Syn4),
VAMP2, and insulin receptor (IR).
|
|
Development and metabolic profiles of VAMP3-deficient mice.
The VAMP3-deficient mice displayed growth and weight gain
characteristics identical to those of wild-type littermates (Fig. 3). Although the older male mice maintain
a greater body weight than female mice, there was no discernible
difference between the wild-type, heterozygotic, and homozygotic
knockout animals. Similarly, all metabolic parameters assessed (serum
glucose, insulin, triglyceride, free fatty acids, and cholesterol) were
not significantly different between the wild-type and VAMP3 null mice
in either the fed or fasted state (Table
1).

View larger version (24K):
[in this window]
[in a new window]
|
FIG. 3.
Deletion of the VAMP3 gene does not affect growth of
VAMP3-deficient mice. Female (F) and male (M) offspring from
heterozygous breedings were weighed every day from days 1 to 21 (A) and
thereafter every 4 weeks from weeks 5 to 25 (B).
|
|
VAMP3-deficient mice display normal glucose tolerance.
Since
VAMP3 has been implicated in certain aspects of GLUT4 translocation, we
next examined the ability of these mice to respond to a glucose
challenge (Fig. 4A). Following a single
intraperitoneal bolus injection of glucose, circulating glucose levels
maximally increased at 30 min and slowly declined over the next 90 min. Essentially identical glucose tolerance curves were obtained for the
VAMP3 null and wild-type mice.

View larger version (21K):
[in this window]
[in a new window]
|
FIG. 4.
VAMP3-deficient mice display normal glucose and insulin
tolerance. (A) GTT of 16-week-old male mice. D-Glucose
(20% solution, 2 g/kg of body weight) was injected intraperitoneally
into mice fasted for 12 h. Blood glucose was measured at 0, 30, 60, 90, and 120 min postinjection using a glucometer as described in Materials
and Methods. (B) ITT of 16 week-old male mice. Insulin (0.75 U/kg of
body weight) was injected intraperitoneally to mice that were fasted
for 6 h. Blood glucose was measured immediately before and at 15, 30, and 60 min after injection as described in Materials and Methods.
The experimental groups consisted of 10 and 6 mice for GTT and ITT,
respectively, and were performed a minimum of three times with similar
results.
|
|
In some circumstances, peripheral tissue insulin resistance can be
compensated for by increased insulin secretion. To determine
their
relative insulin-sensitivities, we subjected these animals
to an ITT
(Fig.
4B). Following a single intraperitoneal insulin
injection, blood
glucose values declined up to 30 min and began
to recover by 60 min. As
observed for glucose tolerance, there
was no significant difference
between the wild-type and VAMP3
knockout mice. Together, these data
indicate that both insulin
secretion and peripheral tissue insulin
sensitivity were unaltered
in the VAMP3 null
animals.
Insulin-stimulated glucose transport in isolated primary adipocytes
and skeletal muscle is normal in VAMP3-deficient mice.
Although
whole-body glucose disposal was unaffected in the VAMP3 null mice, it
was still possible that secondary metabolic factors might compensate
for impaired peripheral tissue glucose transport function. To directly
examine glucose transport activity in insulin-responsive tissues, we
directly determined insulin-stimulated glucose transport in isolated
primary adipocytes (Fig. 5). Consistent with the in vivo results, insulin-stimulated 2-deoxyglucose uptake was
essentially identical in adipocytes isolated from wild-type and VAMP3
null mice.

View larger version (13K):
[in this window]
[in a new window]
|
FIG. 5.
Insulin-stimulated glucose uptake in isolated primary
adipocytes does not differ significantly between wild-type and VAMP3
null mice. Epididymal adipocytes were isolated from 10-week-old males
and incubated in the presence or absence of 100 nM insulin for 30 min.
2-Deoxyglucose transport activity was determined as described in
Materials and Methods. Results are the average ± standard error
from three independent experiments each performed in duplicate.
|
|
Skeletal muscle accounts for the majority of postprandial glucose
disposal in vivo (
15). Examination of soleus muscle
glucose
uptake again demonstrated no significant difference between the
wild-type and knockout mice (Fig.
6A).
Previous studies have shown
that insulin and exercise-contraction
recruit different GLUT4
storage compartments in skeletal muscle through
distinct signaling
pathways (
1,
11,
20,
29-31,
39,
50).
Since hypoxia in
vitro is a commonly used model for exercise-stimulated
glucose
transport (
6,
7,
21,
52), the isolated soleus
muscles
were also made hypoxic and assayed for glucose transport
activity.
Even though hypoxia was a weaker activator of glucose uptake
than
insulin, identical responses were obtained in both wild-type and
VAMP3 null mice. Finally, to examine the effect of exercise in
vivo, we
subjected mice to intense swimming and then determined
glucose uptake
in isolated EDL muscles (Fig.
6B). Acute swimming
led to 2.0- and
2.4-fold increases in glucose transport from the
wild-type and
VAMP3-deficient mice, respectively. Similarly, insulin
stimulation
resulted in 2.4-and 3.0-fold increases, respectively.
Thus, these data
demonstrate that the VAMP3 protein is dispensable
for both adipose and
skeletal muscle tissue insulin-, hypoxia-,
and
exercise-contraction-stimulated glucose uptake.

View larger version (21K):
[in this window]
[in a new window]
|
FIG. 6.
Insulin-, hypoxia-, and exercise-contraction-stimulated
glucose uptake in skeletal muscle is unaffected by the absence of
VAMP3. (A) Soleus muscles were isolated from male wild-type or
VAMP3-deficient mice and incubated for 45 min under oxygenated or
hypoxic (Hyp) conditions with 5 mM glucose at 30°C. The muscles were
transferred to oxygenated glucose-free medium and incubated for an
additional 15 min prior to the initiation of 2-deoxyglucose uptake as
described in Materials and Methods. In parallel, sets of soleus muscle
were incubated in the absence or presence of 120 nM insulin (Ins) for
30 min and assayed for 2-deoxyglucose uptake. (B) Mice either remained
sedentary or were strenuously exercised by swimming as described in
Materials and Methods. EDL muscles were isolated and assayed for
2-deoxyglucose uptake. In parallel, sets of isolated EDL muscles from
sedentary mice were incubated with 120 nM insulin for 30 min and
assayed for 2-deoxyglucose uptake.
|
|
VAMP3 is not essential for phagocytosis.
Previous studies
observed a recruitment of VAMP3 to sites of phagocytosis, suggesting
that VAMP3-containing vesicles may be responsible for the rapid
expansion of the membrane structure around the invaginating
particle (5). Western blots of clarified lysates
demonstrated that VAMP3 was abundant in wild-type BMMs but was
undetectable in BMMs from VAMP3 null mice (Fig.
7A). In contrast, low levels of VAMP2
were present in both types of macrophages (Fig. 7A). To determine
whether VAMP3 was essential for phagocytosis, we assessed the
ability of VAMP3 null and wild-type BMMs to phagocytose zymosan,
IgG-opsonized zymosan, or complement opsonized zymosan particles, which
engage mannose receptors, Fc
receptors, or complement receptors,
respectively (2). In parallel, BMMs were tested for the
ability to ingest the gram-negative bacterium H. pylori or
latex beads. In all cases, phagocytosis was synchronized by centrifugation and internalization of bound particles was assayed after
30 min at 37°C. As shown in Fig. 7B, we found that VAMP3 null BMMs
were indistinguishable from wild-type cells and efficiently ingested
all particles and microbes tested regardless of the phagocytic receptor
engaged.

View larger version (36K):
[in this window]
[in a new window]
|
FIG. 7.
VAMP3 null BMMs phagocytose inert particles and
bacteria. (A) Detection of VAMP2 and VAMP3 in wild-type (WT) and VAMP3
knockout (KO) BMM lysates. (B) H. pylori (Hp), zymosan
particles (Zymo), IgG-opsonized zymosan (IgGZ), or complement-opsonized
zymosan (COZ) was added to cultures of adherent BMMs, and phagocytosis
was synchronized by centrifugation. After 30 min at 37°C, ingestion
of cell-associated particles was scored as described in Materials and
Methods. Data shown are the average ± standard deviation of three
independent experiments performed in triplicate. The absence of VAMP3
did not affect particle binding to BMMs, and attachment indices varied
by less than 15% for each stimulus (data not shown).
|
|
VAMP3 is not required for transferrin receptor recycling or
pinocytosis.
In addition to the trafficking of GLUT4, VAMP3 is
distributed throughout the general endosome recycling system and
colocalizes with the transferrin receptor (14, 34). We
therefore next examined a potential role for VAMP3 in endosome
trafficking in isolated primary mouse embryonic fibroblasts. To
determine the receptor-mediated endocytosis, the cell surface
transferrin receptor was loaded with [125I]transferrin at
4°C and then warmed to 37°C (Fig.
8A). The initial rate of uptake was
essentially the same for the wild-type and VAMP3 null fibroblasts.
Following internalization, the apotransferrin protein is recycled to
the cell surface and released into the medium (26). As
observed in Fig. 8B, the rate of transferrin recycling was not
significantly different between the wild-type and VAMP3-deficient
cells. Similarly, the rate of non-receptor-mediated endocytosis
(pinocytosis) was also unaffected by the loss of the VAMP3 protein
(Fig. 8C). Taken together, these data demonstrate that VAMP3 is
dispensable for multiple aspects of intracellular vesicular trafficking
events.

View larger version (18K):
[in this window]
[in a new window]
|
FIG. 8.
VAMP3 is not essential for transferrin receptor
recycling or pinocytosis in isolated primary mouse embryo fibroblasts.
Embryonic fibroblasts from wild-type and VAMP3-deficient mice were
depleted of bovine transferrin and labeled with
[125I]transferrin (3 nM; 1 µCi/µg) at 4°C for
2 h. Unbound ligand was removed, and then cells were incubated at
37°C for the times indicated. Rates of transferrin internalization
(endocytosis) (A), transferrin release (recycling) (B), and HRP uptake
(pinocytosis) (C) were determined as described in Materials and
Methods. Data shown are the average ± standard deviation of three
independent experiments.
|
|
 |
DISCUSSION |
It is well established that physiological stimuli leading to
enhanced glucose uptake in both striated muscle and adipose tissue primarily result from the recruitment of intracellular
compartmentalized GLUT4 protein to the cell surface membrane (31,
37). Several studies have documented the requirement for the
t-SNARE proteins syntaxin 4 and SNAP23 to interact with their cognate
GLUT4 vesicle protein v-SNAREs, VAMP2 and VAMP3, in the docking and/or
fusion process (9, 32, 37, 47, 48). However, the
relationship between VAMP2 and VAMP3 function in this process is not
entirely clear, as both proteins colocalize with GLUT4 and undergo
similar degrees of translocation to the cell surface (33,
47). In addition, expression of dominant-interfering VAMP2 and
VAMP3 mutants in 3T3-L1 adipocytes is equally effective in inhibiting
insulin-stimulated GLUT4 translocation (37). On the other
hand, introduction of various VAMP-specific toxins has suggested that
VAMP2 plays the major role in mediating insulin-stimulated GLUT4
translocation (9, 40). Furthermore, endosome ablation
using HRP-conjugated transferrin has also provided evidence for VAMP2
but not VAMP3 (32).
To distinguish between the functional properties of VAMP2 and VAMP3 in
a physiological context, we used a mouse homologous recombination
methodology. Our data clearly demonstrate that complete disruption of
VAMP3 expression had no significant effect on whole-body glucose
metabolism or insulin-stimulated glucose uptake. Thus, these data
unequivocally demonstrate that VAMP3 does not play a significant role
in insulin-stimulated glucose transport.
In addition to insulin stimulation, skeletal muscle undergoes a similar
degree of exercise-contraction-stimulated GLUT4 translocation and
glucose uptake (16, 17, 36, 42, 49, 53). Although the
mechanism of exercise-contraction stimulation is not known, this
process occurs independently of PI 3-kinase function (30, 31,
50). Similarly, several other stimuli can induce GLUT4 translocation through a PI 3-kinase-independent mechanism including osmotic shock, uncoupling of oxidative phosphorylation, and GTP
S (10, 18, 51). Thus, it has been postulated that these
alternative signals mediate GLUT4 translocation through a common signal
utilizing a distinct pool of GLUT4 vesicles separate from that of
insulin. In this regard, skeletal muscle has been found to contain
at least two GLUT4-containing intracellular compartments, one enriched for VAMP2 and the other enriched for VAMP3 (1, 39). More importantly, endosome ablation of the VAMP3-containing GLUT4
population, though having no effect on insulin stimulation, was found
to prevent GTP
S-stimulated GLUT4 translocation
(35). Surprisingly, however, the VAMP3 null mice
also did not display any impairment in
exercise-contraction-stimulated glucose uptake. Thus, our data
indicate that VAMP3 is dispensable for both insulin- and
exercise-contraction-stimulated glucose uptake in vivo.
In addition to the potential role in GLUT4 translocation, VAMP3 has
also been suggested to be involved in receptor and
non-receptor-mediated endocytosis (5, 22). Our data
clearly demonstrate that neither phagocytosis, transferrin receptor
recycling, nor fluid-phase endocytosis (pinocytosis) was affected by
the loss of VAMP3. There are several possible mechanisms that could
account for these discrepancies. The most likely is that VAMP2 or some
other v-SNARE protein can compensate for the genetic loss of VAMP3
during muscle and adipose tissue development. Alternatively, VAMP3
function may simply be redundant to ensure fidelity of GLUT4 and
endosome trafficking. In either case, the completely normal
intracellular trafficking of a variety of membrane processes in VAMP3
null mice provides a direct demonstration that VAMP3 is not essential
for general endosome trafficking, phagocytosis, or insulin- or
exercise-contraction-stimulated glucose transport activity in vivo.
 |
ACKNOWLEDGMENTS |
We thank Diana Boeglin for assistance with the glucose tolerance
and insulin tolerance tests. We also thank Ann Davis (Bayer) for
helpful discussion the design of the VAMP3 targeting vector.
This work was supported by research grants DK33823, DK55811, and
DK25295 from the National Institutes of Health. S.M. is a recipient of
a postdoctoral fellowship (Formación de Personal Investigador)
from the Ministerio de Educación y Cultura, Spain. L.-A.A. is a
recipient of a Merit Review award from the Veterans Administration.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Physiology and Biophysics, The University of Iowa, Iowa City, IA 52242. Phone: (319) 335-7823. Fax: (319) 335-7886. E-mail:
Jeffrey-Pessin{at}uiowa.edu.
Present address: Lexicon Genetics Incorporated, The Woodlands, TX 77381.
 |
REFERENCES |
| 1.
|
Aledo, J. C.,
L. Lavoie,
A. Volchuck,
S. R. Keller,
A. Klip, and H. S. Hundal.
1997.
Identification and characterization of two distinct intracellular GLUT4 pools in rat skeletal muscle: evidence for an endosomal and an insulin-sensitive GLUT4 compartment.
Biochem. J.
325:727-732.
|
| 2.
|
Allen, L. A., and A. Aderem.
1996.
Molecular definition of distinct cytoskeletal structures involved in complement-and Fc receptor-mediated phagocytosis in macrophages.
J. Exp. Med.
184:627-637[Abstract/Free Full Text].
|
| 3.
|
Allen, L. A.,
L. S. Schlesinger, and B. Kang.
2000.
Virulent strains of Helicobacter pylori demonstrate delayed phagocytosis and stimulate homotypic phagosome fusion in macrophages.
J. Exp. Med.
191:115-128[Abstract/Free Full Text].
|
| 4.
|
Allen, L. H., and A. Aderem.
1995.
A role for MARCKS, the alpha isozyme of protein kinase C and myosin I in zymosan phagocytosis by macrophages.
J. Exp. Med.
182:829-840[Abstract/Free Full Text].
|
| 5.
|
Bajno, L.,
X. R. Peng,
A. D. Schreiber,
H. P. Moore,
W. S. Trimble, and S. Grinstein.
2000.
Focal exocytosis of VAMP3-containing vesicles at sites of phagosome formation.
J. Cell Biol.
149:697-706[Abstract/Free Full Text].
|
| 6.
|
Brozinick, J. T., Jr.,
S. C. McCoid,
T. H. Reynolds,
C. M. Wilson,
R. W. Stevenson,
S. W. Cushman, and E. M. Gibbs.
1997.
Regulation of cell surface GLUT4 in skeletal muscle of transgenic mice.
Biochem. J.
321:75-81.
|
| 7.
|
Cartee, G. D.,
A. G. Douen,
T. Ramlal,
A. Klip, and J. O. Holloszy.
1991.
Stimulation of glucose transport in skeletal muscle by hypoxia.
J. Appl. Physiol.
70:1593-1600[Abstract/Free Full Text].
|
| 8.
|
Ceresa, B. P.,
A. W. Kao,
S. R. Santeler, and J. E. Pessin.
1998.
Inhibition of clathrin-mediated endocytosis selectively attenuates specific insulin receptor signal transduction pathways.
Mol. Cell. Biol.
18:3862-3870[Abstract/Free Full Text].
|
| 9.
|
Cheatham, B.,
A. Volchuk,
C. R. Kahn,
L. Wang,
C. J. Rhodes, and A. Klip.
1996.
Insulin-stimulated translocation of GLUT4 glucose transporters requires SNARE-complex proteins.
Proc. Natl. Acad. Sci. USA
93:15169-15173[Abstract/Free Full Text].
|
| 10.
|
Chen, D.,
J. S. Elmendorf,
A. L. Olson,
X. Li,
H. S. Earp, and J. E. Pessin.
1997.
Osmotic shock stimulates GLUT4 translocation in 3T3L1 adipocytes by a novel tyrosine kinase pathway.
J. Biol. Chem.
272:27401-27410[Abstract/Free Full Text].
|
| 11.
|
Coderre, L.,
K. V. Kandror,
G. Vallega, and P. F. Pilch.
1995.
Identification and characterization of an exercise-sensitive pool of glucose transporters in skeletal muscle.
J. Biol. Chem.
270:27584-27588[Abstract/Free Full Text].
|
| 12.
|
Czech, M. P.
1995.
Molecular actions of insulin on glucose transport.
Annu. Rev. Nutr.
15:441-471[CrossRef][Medline].
|
| 13.
|
Daro, E.,
D. Sheff,
M. Gomez,
T. Kreis, and I. Mellman.
1997.
Inhibition of endosome function in CHO cells bearing a temperature-sensitive defect in the coatomer (COPI) component e-COP.
J. Cell Biol.
139:1747-1759[Abstract/Free Full Text].
|
| 14.
|
Daro, E.,
P. V. Sluijs,
T. Galli, and I. Mellman.
1996.
Rab4 and cellubrevin define different early endosome populations on the pathway of transferrin receptor recycling.
Proc. Natl. Acad. Sci. USA
93:9559-9564[Abstract/Free Full Text].
|
| 15.
|
DeFronzo, R. A.,
E. Jacot,
E. Jequier,
E. Maeder,
J. Wahren, and J. P. Felber.
1981.
The effect of insulin on the disposal of intravenous glucose. Results from indirect calorimetry and hepatic and femoral venous catheterization.
Diabetes
30:1000-1007[Medline].
|
| 16.
|
Douen, A. G.,
T. Ramlal,
A. Klip,
D. A. Young,
G. D. Cartee, and J. O. Holloszy.
1989.
Exercise-induced increase in glucose transporters in plasma membranes of rat skeletal muscle.
Endocrinology
24:449-454.
|
| 17.
|
Douen, A. G.,
T. Ramlal,
S. Rastogi,
P. J. Bilan,
G. D. Cartee,
M. Vranic,
J. O. Holloszy, and A. Klip.
1990.
Exercise induces recruitment of the "insulin-responsive glucose transporter." Evidence for distinct intracellular insulin- and exercise-recruitable transporter pools in skeletal muscle.
J. Biol. Chem.
265:13427-13430[Abstract/Free Full Text].
|
| 18.
|
Elmendorf, J. S.,
D. Chen, and J. E. Pessin.
1998.
Guanosine 5'-0-(3-thiotriphosphate) (GTPgammaS) stimulation of GLUT4 translocation is tyrosine kinase-dependent.
J. Biol. Chem.
273:13289-13296[Abstract/Free Full Text].
|
| 19.
|
Enrique-Tarancon, G.,
L. Marti,
N. Morin,
J. M. Lizcano,
M. Unzeta,
L. Sevilla,
M. Camps,
M. Palacin,
X. Testar,
C. Carpene, and A. Zorzano.
1998.
Role of semicarbazide-sensitive amine oxidase on glucose transport and GLUT4 recruitment to the cell surface in adipose cells.
J. Biol. Chem.
273:8025-8032[Abstract/Free Full Text].
|
| 20.
|
Goodyear, L. J.,
F. Giorgino,
T. W. Balon,
G. Condorelli, and R. J. Smith.
1995.
Effects of contractile activity on tyrosine phosphoproteins and PI 3-kinase activity in rat skeletal muscle.
Am. J. Physiol.
268:E987-E995[Abstract/Free Full Text].
|
| 21.
|
Gulve, E. A.,
J. M. Ren,
B. A. Marshall,
J. Gao,
P. A. Hansen,
J. O. Holloszy, and M. Mueckler.
1994.
Glucose transport activity in skeletal muscles from transgenic mice overexpressing GLUT1. Increased basal transport is associated with a defective response to diverse stimuli that activate GLUT4.
J. Biol. Chem.
269:18366-18370[Abstract/Free Full Text].
|
| 22.
|
Hackam, D. J.,
O. D. Rotstein,
C. Sjolin,
A. D. Schreiber,
W. S. Trimble, and S. Grinstein.
1998.
v-SNARE-dependent secretion is required for phagocytosis.
Proc. Natl. Acad. Sci. USA
95:11691-11696[Abstract/Free Full Text].
|
| 23.
|
Hansen, P. A.,
E. A. Gulve,
B. A. Marshall,
J. Gao,
J. E. Pessin,
J. O. Holloszy, and M. Mueckler.
1995.
Skeletal muscle glucose transport and metabolism are enhanced in transgenic mice overexpressing the Glut4 glucose transporter.
J. Biol. Chem.
270:1679-1684[Free Full Text].
|
| 24.
|
Heesemann, J., and R. Laufs.
1985.
Double immunofluorescence microscopic technique for accurate differentiation of extracellularly and intracellularly located bacteria in cell culture.
J. Clin. Microbiol.
22:168-175[Abstract/Free Full Text].
|
| 25.
|
Hogan, B.,
R. Beddington,
F. Costantini, and E. Lacy.
1994.
Manipulating the mouse embryo, 2nd ed.
Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
|
| 26.
|
Hopkins, C. R., and I. S. Trowbridge.
1983.
Internalization and processing of transferrin and the transferrin receptor in human carcinoma A431 cells.
J. Cell Biol.
97:508-521[Abstract/Free Full Text].
|
| 27.
|
Kandror, K. V., and P. F. Pilch.
1996.
Compartmentalization of protein traffic in insulin-sensitive cells.
Am. J. Physiol.
271:E1-E14[Abstract/Free Full Text].
|
| 28.
|
Kao, A. W.,
B. P. Ceresa,
S. R. Santeler, and J. E. Pessin.
1998.
Expression of a dominant interfering dynamin mutant in 3T3L1 adipocytes inhibits GLUT4 endocytosis without affecting insulin signaling.
J. Biol. Chem.
273:25450-25457[Abstract/Free Full Text].
|
| 29.
|
Koval, J. A.,
K. Maezono,
M. E. Patti,
M. Pendergrass,
R. A. DeFronzo, and L. J. Mandarino.
1999.
Effects of exercise and insulin on insulin signaling proteins in human skeletal muscle.
Med. Sci. Sports Exerc.
31:998-1004[Medline].
|
| 30.
|
Lee, A. D.,
P. A. Hansen, and J. O. Holloszy.
1995.
Wortmannin inhibits insulin-stimulated but not contraction-stimulated glucose transport activity in skeletal muscle.
FEBS Lett.
361:51-54[CrossRef][Medline].
|
| 31.
|
Lund, S.,
G. D. Holman,
O. Schmitz, and O. Pedersen.
1995.
Contraction stimulates translocation of glucose transporter GLUT4 in skeletal muscle through a mechanism distinct from that of insulin.
Proc. Natl. Acad. Sci. USA
92:5817-5821[Abstract/Free Full Text].
|
| 32.
|
Martin, L. B.,
A. Shewan,
C. A. Millar,
G. W. Gould, and D. E. James.
1998.
Vesicle-associated membrane protein 2 plays a specific role in the insulin-dependent trafficking of the facilitative glucose transporter GLUT4 in 3T3-L1 adipocytes.
J. Biol. Chem.
273:1444-1452[Abstract/Free Full Text].
|
| 33.
|
Martin, S.,
J. Tellam,
C. Livingstone,
J. W. Slot,
G. W. Gould, and D. E. James.
1996.
The glucose transporter (GLUT-4) and vesicle-associated membrane protein-2 (VAMP-2) are segregated from recycling endosomes in insulin-sensitive cells.
J. Cell Biol.
134:625-635[Abstract/Free Full Text].
|
| 34.
|
McMahon, H. T.,
Y. A. Ushkaryov,
L. Edelmann,
E. Link,
T. Binz,
H. Niemann,
R. Jahn, and T. C. Sudhof.
1993.
Cellubrevin is a ubiquitous tetanus-toxin substrate homologous to a putative synaptic vesicle fusion protein.
Nature
364:346-349[CrossRef][Medline].
|
| 35.
|
Millar, C. A.,
A. Shewan,
G. R. Hickson,
D. E. James, and G. W. Gould.
1999.
Differential regulation of secretory compartments containing the insulin-responsive glucose transporter 4 in 3T3-L1 adipocytes.
Mol. Biol. Cell.
10:3675-3688[Abstract/Free Full Text].
|
| 36.
|
Nesher, R.,
I. E. Karl, and D. M. Kipnis.
1985.
Dissociation of effects of insulin and contraction on glucose transport in rat epitrochlearis muscle.
Am. J. Physiol.
249:C226-C232[Abstract/Free Full Text].
|
| 37.
|
Olson, A. L.,
J. B. Knight, and J. E. Pessin.
1997.
Syntaxin 4, VAMP2, and/or VAMP3/cellubrevin are functional target membrane and vesicle SNAP receptors for insulin-stimulated GLUT4 translocation in adipocytes.
Mol. Cell. Biol.
17:2425-2435[Abstract].
|
| 38.
|
Pessin, J. E.,
D. C. Thurmond,
J. S. Elmendorf,
K. J. Coker, and S. Okada.
1999.
Molecular basis of insulin-stimulated GLUT4 vesicle trafficking. Location! Location! Location!
J. Biol. Chem.
274:2593-2596[Free Full Text].
|
| 39.
|
Ploug, T.,
B. van Deurs,
H. Ai,
S. W. Cushman, and E. Ralston.
1998.
Analysis of GLUT4 distribution in whole skeletal muscle fibers: identification of distinct storage compartments that are recruited by insulin and muscle contractions.
J. Cell Biol.
142:1429-1446[Abstract/Free Full Text].
|
| 40.
|
Randhawa, V. K.,
P. J. Bilan,
Z. A. Khayat,
N. Daneman,
Z. Liu,
T. Ramlal,
A. Volchuk,
X. R. Peng,
T. Coppola,
R. Regazzi,
W. S. Trimble, and A. Klip.
2000.
VAMP2, but not VAMP3/cellubrevin, mediates insulin-dependent incorporation of GLUT4 into the plasma membrane of L6 myoblasts.
Mol. Biol. Cell
11:2403-2417[Abstract/Free Full Text].
|
| 41.
|
Rea, S., and D. E. James.
1997.
Moving GLUT4. The biogenesis and trafficking of GLUT4 storage vesicles.
Diabetes
46:1667-1677[Abstract].
|
| 42.
|
Richter, E. A.,
T. Ploug, and H. Galbo.
1985.
Increased muscle glucose uptake after exercise. No need for insulin during exercise.
Diabetes
34:1041-1048[Abstract].
|
| 43.
|
Ryder, J. W.,
Y. Kawano,
D. Galuska,
R. Fahlman,
H. Wallberg-Henriksson,
M. J. Charron, and J. R. Zierath.
1999.
Postexercise glucose uptake and glycogen synthesis in skeletal muscle from GLUT4-deficient mice.
FASEB J.
13:2246-2256[Abstract/Free Full Text].
|
| 44.
|
Slot, J. W.,
H. J. Geuze,
S. Gigengack,
D. E. James, and G. E. Lienhard.
1991a.
Translocation of the glucose transporter GLUT4 in cardiac myocytes of the rat.
Proc. Natl. Acad. Sci. USA
88:7815-7819[Abstract/Free Full Text].
|
| 45.
|
Slot, J. W.,
H. J. Geuze,
S. Gigengack,
G. E. Lienhard, and D. E. James.
1991b.
Immuno-localization of the insulin regulatable glucose transporter in brown adipose tissue of the rat.
J. Cell Biol.
113:123-135[Abstract/Free Full Text].
|
| 46.
|
Thurmond, D. C.,
B. P. Ceresa,
S. Okada,
J. S. Elmendorf,
K. Coker, and J. E. Pessin.
1998.
Regulation of insulin-stimulated GLUT4 translocation by Munc18c in 3T3L1 adipocytes.
J. Biol. Chem.
273:33876-33883[Abstract/Free Full Text].
|
| 47.
|
Volchuk, A.,
R. Sargeant,
S. Sumitani,
Z. Liu,
L. He, and A. Klip.
1995.
Cellubrevin is a resident protein of insulin-sensitive GLUT4 glucose transporter vesicles in 3T3-L1 adipocytes.
J. Biol. Chem.
270:8233-8240[Abstract/Free Full Text].
|
| 48.
|
Volchuk, A.,
Q. Wang,
H. S. Ewart,
Z. Liu,
L. He,
M. K. Bennett, and A. Klip.
1996.
Syntaxin 4 in 3T3-L1 adipocytes: regulation by insulin and participation in insulin-dependent glucose transport.
Mol. Biol. Cell
7:1075-1082[Abstract].
|
| 49.
|
Wallberg-Henriksson, H., and J. O. Holloszy.
1985.
Activation of glucose transport in diabetic muscle: responses to contraction and insulin.
Am. J. Physiol.
249:C233-C237[Abstract/Free Full Text].
|
| 50.
|
Yeh, J. I.,
E. A. Gulve,
L. Rameh, and M. J. Birnbaum.
1995.
The effects of wortmannin on rat skeletal muscle. Dissociation of signaling pathways for insulin- and contraction-activated hexose transport.
J. Biol. Chem.
270:2107-2111[Abstract/Free Full Text].
|
| 51.
|
Zhang, J. Z.,
A. Behrooz, and F. Ismail-Beigi.
1999.
Regulation of glucose transport by hypoxia.
Am. J. Kidney Dis.
34:189-202[Medline].
|
| 52.
|
Zierath, J. R.,
K. L. Houseknecht,
L. Gnudi, and B. B. Kahn.
1997.
High-fat feeding impairs insulin-stimulated GLUT4 recruitment via an early insulin-signaling defect.
Diabetes
46:215-223[Abstract].
|
| 53.
|
Zorzano, A.,
T. W. Balon,
M. N. Goodman, and N. B. Ruderman.
1986.
Additive effects of prior exercise and insulin on glucose and AIB uptake by rat muscle.
Am. J. Physiol.
251:E21-E26[Abstract/Free Full Text].
|
Molecular and Cellular Biology, March 2001, p. 1573-1580, Vol. 21, No. 5
0270-7306/01/$04.00+0 DOI: 10.1128/MCB.21.5.1573-1580.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Schulert, G. S., McCaffrey, R. L., Buchan, B. W., Lindemann, S. R., Hollenback, C., Jones, B. D., Allen, L.-A. H.
(2009). Francisella tularensis Genes Required for Inhibition of the Neutrophil Respiratory Burst and Intramacrophage Growth Identified by Random Transposon Mutagenesis of Strain LVS. Infect. Immun.
77: 1324-1336
[Abstract]
[Full Text]
-
Ho, Y. H. S., Cai, D. T., Wang, C.-C., Huang, D., Wong, S. H.
(2008). Vesicle-Associated Membrane Protein-8/Endobrevin Negatively Regulates Phagocytosis of Bacteria in Dendritic Cells. J. Immunol.
180: 3148-3157
[Abstract]
[Full Text]
-
Puri, N., Roche, P. A.
(2008). Mast cells possess distinct secretory granule subsets whose exocytosis is regulated by different SNARE isoforms. Proc. Natl. Acad. Sci. USA
105: 2580-2585
[Abstract]
[Full Text]
-
Wang, C.-C., Shi, H., Guo, K., Ng, C. P., Li, J., Qi Gan, B., Chien Liew, H., Leinonen, J., Rajaniemi, H., Hong Zhou, Z., Zeng, Q., Hong, W.
(2007). VAMP8/Endobrevin as a General Vesicular SNARE for Regulated Exocytosis of the Exocrine System. Mol. Biol. Cell
18: 1056-1063
[Abstract]
[Full Text]
-
Ren, Q., Barber, H. K., Crawford, G. L., Karim, Z. A., Zhao, C., Choi, W., Wang, C.-C., Hong, W., Whiteheart, S. W.
(2007). Endobrevin/VAMP-8 Is the Primary v-SNARE for the Platelet Release Reaction. Mol. Biol. Cell
18: 24-33
[Abstract]
[Full Text]
-
Deak, F., Shin, O.-H., Kavalali, E. T., Sudhof, T. C.
(2006). Structural determinants of synaptobrevin 2 function in synaptic vesicle fusion.. J. Neurosci.
26: 6668-6676
[Abstract]
[Full Text]
-
Proux-Gillardeaux, V., Gavard, J., Irinopoulou, T., Mege, R.-M., Galli, T.
(2005). Tetanus neurotoxin-mediated cleavage of cellubrevin impairs epithelial cell migration and integrin-dependent cell adhesion. Proc. Natl. Acad. Sci. USA
102: 6362-6367
[Abstract]
[Full Text]
-
Randhawa, V. K., Thong, F. S.L., Lim, D. Y., Li, D., Garg, R. R., Rudge, R., Galli, T., Rudich, A., Klip, A.
(2004). Insulin and Hypertonicity Recruit GLUT4 to the Plasma Membrane of Muscle Cells by Using N-Ethylmaleimide-sensitive Factor-dependent SNARE Mechanisms but Different v-SNAREs: Role of TI-VAMP. Mol. Biol. Cell
15: 5565-5573
[Abstract]
[Full Text]
-
Watson, R. T., Kanzaki, M., Pessin, J. E.
(2004). Regulated Membrane Trafficking of the Insulin-Responsive Glucose Transporter 4 in Adipocytes. Endocr. Rev.
25: 177-204
[Abstract]
[Full Text]
-
Schraw, T. D., Rutledge, T. W., Crawford, G. L., Bernstein, A. M., Kalen, A. L., Pessin, J. E., Whiteheart, S. W.
(2003). Granule stores from cellubrevin/VAMP-3 null mouse platelets exhibit normal stimulus-induced release. Blood
102: 1716-1722
[Abstract]
[Full Text]
-
Atlashkin, V., Kreykenbohm, V., Eskelinen, E.-L., Wenzel, D., Fayyazi, A., Fischer von Mollard, G.
(2003). Deletion of the SNARE vti1b in Mice Results in the Loss of a Single SNARE Partner, Syntaxin 8. Mol. Cell. Biol.
23: 5198-5207
[Abstract]
[Full Text]
-
Martinez-Arca, S., Proux-Gillardeaux, V., Alberts, P., Louvard, D., Galli, T.
(2003). Ectopic expression of syntaxin 1 in the ER redirects TI-VAMP- and cellubrevin-containing vesicles. J. Cell Sci.
116: 2805-2816
[Abstract]
[Full Text]
-
Allen, L.-A. H., Yang, C., Pessin, J. E.
(2002). Rate and extent of phagocytosis in macrophages lacking vamp3. J. Leukoc. Biol.
72: 217-221
[Abstract]
[Full Text]